152 related articles for article (PubMed ID: 37842767)
1. A systematic review of clozapine-associated inflammation and related monitoring.
Leung JG; Zhang L; Markota M; Ellingrod VL; Gerberi DJ; Bishop JR
Pharmacotherapy; 2023 Dec; 43(12):1364-1396. PubMed ID: 37842767
[TBL] [Abstract][Full Text] [Related]
2. Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
Griffin JM; Woznica E; Gilotra NA; Nucifora FC
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):180-185. PubMed ID: 33587399
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein: an early critical sign of clozapine-related myocarditis.
Fehily SR; Forlano R; Fitzgerald PB
Australas Psychiatry; 2016 Apr; 24(2):181-4. PubMed ID: 26400456
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of clozapine-induced myocarditis.
Bellissima BL; Tingle MD; Cicović A; Alawami M; Kenedi C
Int J Cardiol; 2018 May; 259():122-129. PubMed ID: 29579587
[TBL] [Abstract][Full Text] [Related]
5. Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review.
Verdoux H; Quiles C; de Leon J
Schizophr Res; 2019 Sep; 211():1-9. PubMed ID: 31378552
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.
Richardson N; Greenway SC; Bousman CA
Psychiatry Res; 2021 Nov; 305():114247. PubMed ID: 34715441
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review.
Smessaert S; Detraux J; Desplenter F; De Hert M
CNS Drugs; 2024 Feb; 38(2):105-123. PubMed ID: 38236524
[TBL] [Abstract][Full Text] [Related]
8. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
Knoph KN; Morgan RJ; Palmer BA; Schak KM; Owen AC; Leloux MR; Patel M; Leung JG
Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
[TBL] [Abstract][Full Text] [Related]
9. Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
Kikuchi Y; Komatsu H; Otsuka Y; Ito F; Yada Y; Tanifuji H; Tomita H
Psychiatry Res; 2024 Apr; 334():115810. PubMed ID: 38382186
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls.
Ronaldson KJ; Taylor AJ; Fitzgerald PB; Topliss DJ; Elsik M; McNeil JJ
J Clin Psychiatry; 2010 Aug; 71(8):976-81. PubMed ID: 20361910
[TBL] [Abstract][Full Text] [Related]
11. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls.
Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; McNeil JJ
Aust N Z J Psychiatry; 2011 Jun; 45(6):458-65. PubMed ID: 21524186
[TBL] [Abstract][Full Text] [Related]
12. Should we routinely add CRP to clozapine titrations? - Learning from three cases.
Shelton C; Ruan CJ; Ertuğrul A; Cotes RO; De Leon J
Neuropsychopharmacol Hung; 2022 Dec; 24(4):153-161. PubMed ID: 36775960
[TBL] [Abstract][Full Text] [Related]
13. Should C-Reactive Protein and Troponin Be Monitored for Early Diagnosis of Clozapine Induced Myocarditis? An Assessment Within the Framework of Two Cases.
Balaban ÖD; Parsanoğlu Z; Arıkan Ö; Gül Ö
Turk Psikiyatri Derg; 2021; 32(1):56-60. PubMed ID: 34181745
[TBL] [Abstract][Full Text] [Related]
14. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases.
Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; McNeil JJ
Schizophr Res; 2011 May; 128(1-3):161-5. PubMed ID: 21320766
[TBL] [Abstract][Full Text] [Related]
15. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
[TBL] [Abstract][Full Text] [Related]
16. Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy.
Segev A; Iqbal E; McDonagh TA; Casetta C; Oloyede E; Piper S; Plymen CM; MacCabe JH
Br J Psychiatry; 2021 Dec; 219(6):644-651. PubMed ID: 35048875
[TBL] [Abstract][Full Text] [Related]
17. Transient Clozapine-induced Myocarditis Without Discontinuation of Medication: A Series of 2 Patients.
Klein N; Barnett L; Guirgis H; Stearns WH
J Psychiatr Pract; 2022 Mar; 28(2):170-175. PubMed ID: 35238829
[TBL] [Abstract][Full Text] [Related]
18. Elevated clozapine levels associated with infection: A systematic review.
Clark SR; Warren NS; Kim G; Jankowiak D; Schubert KO; Kisely S; Forrester T; Baune BT; Siskind DJ
Schizophr Res; 2018 Feb; 192():50-56. PubMed ID: 28392207
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-induced myocarditis during co-administration of valproate: A case report.
Jahołkowski P; Niewiadomska J; Wciórka J; Kowalski M; Świtaj P
Psychiatr Pol; 2019 Oct; 53(5):997-1002. PubMed ID: 31955181
[TBL] [Abstract][Full Text] [Related]
20. Myocarditis after administration of clozapine.
Kontoangelos K; Loizos S; Kanakakis J; Smyrnis N; Economou M; Bergiannaki JD; Papadimitriou GN
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2383-6. PubMed ID: 25219841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
